Oral Janus kinase/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis

2019140 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Allergy and Clinical Immunology

Volume 144, Issue 4, pp. 1011-1024

Field-Weighted Citation Impact: 15.36